首页> 外文期刊>Asian Journal of Medical Sciences >Clinical profile and outcome of HIV-TB Co?Infection at a centre of excellence for HIV care
【24h】

Clinical profile and outcome of HIV-TB Co?Infection at a centre of excellence for HIV care

机译:HIV护理卓越中心的HIV-TB Co?感染的临床概况和结果

获取原文
       

摘要

Background: Tuberculosis (TB) and Human Imuunodeficiency Virus (HIV) co-infection has detrimental effects on both the individual and the health care system especially in resource limited countries like India. Tuberculosis ranks among the most common cause of death in HIV patients. In this review we have analysed the clinical and immunological characteristics of HIV-TB coinfected patients and their clinical outcomes. Aims and Objectives: To assess the co-relation between socio-demographic characteristics, clinical and immunological Profile of HIV-TB co-infected patients and the clinical outcome. Materials and Methods: A retrospective clinical study of patient records at the Centre of Excellence for anti-retroviral therapy was done. The records of HIV-TB co-infected patients were collected and data extracted pertaining to the socio- demographic characteristics, clinical profiles and outcomes. Results: Among the 377 cases included as per criteria, 76.9 % completed the treatment for TB while 23.1% patients died before treatment completion. Twenty-nine point seven percent of the patient population constituted women, while 0.5% was transgenders. Regarding the pattern of tuberculosis, 58.4% patients had extra pulmonary TB while 39.5% and 2.1% of the study population were diagnosed as pulmonary and disseminated TB respectively. Mean baseline CD4 count was 191 cells/mm3 and the mean CD4 count during first and second follow up were 298 and 362 cells/mm3 respectively. There was a statistically significant correlation noted with poor clinical outcomes and low baseline CD4 counts. Conclusion: Age, gender, the clinical pattern of tuberculosis and the treatment category did not have a statistically significant association on the outcome. We found that the TB associated mortality in HIV co-infected patients had a direct correlation with the stage of HIV at presentation as there was a strongly significant association between low CD4 counts and adverse clinical outcomes. Asian Journal of Medical Sciences Vol.9(2) 2018 19-24.
机译:背景:结核病(TB)和人类免疫缺陷病毒(HIV)共同感染对个人和医疗保健系统均具有有害影响,尤其是在印度等资源有限的国家。结核病是HIV患者最常见的死亡原因之一。在这篇综述中,我们分析了HIV-TB合并感染患者的临床和免疫学特征及其临床结局。目的和目的:评估社会人口学特征,HIV-TB合并感染患者的临床和免疫学特征与临床结局之间的相互关系。材料和方法:在卓越中心进行了抗逆转录病毒治疗的患者记录回顾性临床研究。收集了艾滋病毒/结核病合并感染患者的记录,并提取了有关社会人口统计学特征,临床概况和结果的数据。结果:在按标准纳入的377例患者中,有76.9%的患者完成了结核治疗,而23.1%的患者在治疗完成前死亡。 29%的患者中有7%是女性,而0.5%是跨性别者。关于肺结核的类型,有58.4%的患者患有额外的肺结核,而分别有39.5%和2.1%的患者被诊断为肺结核和弥散性结核。平均基线CD4计数为191细胞/ mm3,第一次和第二次随访期间的平均CD4计数分别为298和362细胞/ mm3。在临床结果差和基线CD4计数低的情况下,存在统计学上的显着相关性。结论:年龄,性别,结核病的临床模式和治疗类别与结局无统计学意义。我们发现,HIV合并感染患者中与结核病相关的死亡率与呈报时的HIV分期有直接相关性,因为CD4计数低与不良临床结果之间存在强烈的关联。亚洲医学杂志Vol.9(2)2018 19-24。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号